On Wednesday, Shares of Rite Aid Corporation (NYSE:RAD), gained 0.68% to $8.90.
Rite Aid Corporation declared that seasonal flu shots are now accessible at all Rite Aid pharmacies nationwide. Customers can visit any of Rite Aid’s nearly 4,600 pharmacies to receive a flu shot from a certified immunizing Rite Aid pharmacist, subject to state regulations. Flu shots are covered by most insurance plans, counting Medicare Part B and are accessible during pharmacy hours; no appointment is necessary.
Rite Aid carries the standard trivalent flu vaccine, which offers protection against three strains of the flu: the influenza A H3N2 virus, the influenza B virus and the influenza A H1N1. Additionally, a quadrivalent flu vaccine that offers protection against an additional influenza B virus will also be accessible. The Centers for Disease Control and Prevention (CDC) recommends that everyone six months and older get a flu vaccination as soon as it is accessible, since it takes about two weeks after vaccination for antibodies to develop in the body and provide protection against the flu.
Rite Aid Corporation, through its auxiliaries, operates a chain of retail drugstores in the United States. The company sells prescription drugs and a range of other merchandise, counting over-the-counter medications, health and beauty aids, personal care items, cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, and other every day and convenience products.
Shares of Baxter International Inc. (NYSE:BAX), declined -2.25% to $40.82, during its last trading session.
Baxter International issued the following statement in response to the Plan 13D filed by Third Point LLC:
Baxter maintains open communication with its shareholders and values constructive input toward enhancing value. Baxter has engaged in various discussions with representatives of Third Point and anticipates to continue a constructive dialogue.
Baxter’s Board and administration team are committed to enhancing value for all Baxter shareholders. Baxter has a proven track record of taking action to create noteworthy value and will continue to evaluate shareholder input, assess opportunities and make decisions to further achieve this important objective.
Baxter International Inc., develops, manufactures, and markets products for people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions.
Finally, Archer-Daniels-Midland Company (NYSE:ADM), ended its last trade with 1.78% gain, and closed at $46.89.
Archer-Daniels-Midland Company’s Board of Directors has declared a cash dividend of 28.0 cents per share on the company’s common stock payable Sept. 9, 2015, to Stockholders of record Aug. 19, 2015.
This is ADM’s 335th successive quarterly payment, a record of 83 years of uninterrupted dividends. As of June 30, 2015, there were 613,707,010 shares of ADM common stock outstanding.
Archer-Daniels-Midland Company procures, transports, stores, processes, and merchandises agricultural commodities and products. The company’s Oilseeds Processing segment originates, merchandises, crushes, and processes soybeans and soft seeds into vegetable oils and protein meals.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified with such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
